Pulmonary Type B Niemann-Pick Disease Successfully Treated with Lung Transplantation

Autor: R. S. O’Neill, N. Belousova, M. A. Malouf

Publikováno v: Case Reports in Transplantation, Vol 2019 (2019)

Background. Niemann-Pick Disease (NPD) type B is a rare autosomal recessive disease characterised by hepatosplenomegaly and pulmonary disease, highlighted by preserved volumes and diminished diffusion capacity of the lung for carbon monoxide (DLCO) o

Externí odkaz: https://doaj.org/article/28018ae663aa49d791aaeb78e57cdd40

Non-surgical management of patients with ectopic pregnancy: A review

Autor: Yulia E. Dobrokhotova, Tamara N. Belousova, Ekaterina I. Borovkova, Nikolai I. Sovaev, Vera D. Egorushkina, Anastasia D. Kladnitskaya, Anna Ermakova

Publikováno v: Гинекология, Vol 25, Iss 4, Pp 435-441 (2023)

An ectopic pregnancy is a medical emergency. Currently, surgery is the main method of therapy, and non-surgical management with methotrexate is considered an acceptable alternative. Methotrexate is a folic acid antagonist and has an inhibitory effect

Externí odkaz: https://doaj.org/article/b9d97771ef3b45d981458f7d5c6a2db5

Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAMMA (Clinical registry on patient population with polyvascular disease in the Russian Federation and Eurasian countries)

Autor: G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, T. I. Batluk, N. A. Koziolova, A. I. Chesnikova, A. Y. Vaskin, D. S. Tokmin, I. G. Bakulin, O. L. Barbarash, N. U. Grigoryeva, I. V. Gubareva, N. V. Izmozherova, U. K. Kamilova, S. G. Kechedzhieva, Z. F. Kim, N. A. Koriagina, S. V. Mironova, N. P. Mitkovskaya, S. V. Nemirova, L. M. Nurieva, M. M. Petrova, E. A. Polyanskaya, A. P. Rebrov, A. V. Svarovskaya, E. A. Smirnova, A. B. Sugraliev, Y. B. Khovaeva, G. V. Shavkuta, I. I. Shaposhnik, M. Y. Alieva, A. B. Almukhanova, A. V. Aparkina, R. A. Bashkinov, L. N. Belousova, E. I. Blokhina, V. O. Bochkareva, M. V. Buianova, F. Y. Valikulova, A. D. Vende, A. S. Galyavich, V. V. Genkel, E. V. Gorbunova, E. D. Gordeychuk, E. A. Grigorenko, E. V. Grigoryeva, I. L. Davydkin, D. S. Evdokimov, A. N. Ermilova, S. B. Zhangelova, N. V. Zhdankina, E. I. Zheleznyak, N. S. Ilyanok, D. A. Kapsultanova, N. A. Karoli, E. A. Kartashova, A. S. Kuznetsova, A. T. Kumaritova, N. A. Magdeeva, S. A. Makarov, E. S. Melnikov, M. V. Novikova, I. A. Obukhova, E. V. Ponomarenko, A. O. Rubanenko, O. A. Rubanenko, F. E. Rustamova, V. A. Safronenko, E. I. Suchkova, A. I. Sycheva, D. R. Tagaeva, M. A. Trubnikova, T. P. Trunina, A. G. Frolov, V. V. Khatlamadzhiyan, Y. I. Khokhlova, A. I. Chernyavina, O. Y. Chizhova, M. A. Shambatov, T. V. Shnyukova, Y. V. Shchukin

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 4 (2024)

Aim. To investigate the prevalence and characteristics of polyvascular disease in the Eurasian region's population with one or more previously established locations of atherosclerotic arterial damage, and to evaluate the diagnostic importance of the

Externí odkaz: https://doaj.org/article/f98daca5abd24d6487deebf4884d2cd2

Course of COVID-19 in Patients with Inflammatory Bowel Disease: Regional Experience

Autor: L. M. Kupkenova, E. N. Belousova, E. S. Bodryagina, D. D. Mukhametova, A. Kh. Odintsova, D. G. Iskhakova, D. I. Abdulganieva

Publikováno v: Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 32, Iss 5, Pp 63-69 (2023)

Aim: to study the course of COVID-19 in patients with inflammatory bowel diseases (IBD) using the example of the region of the Republic of Tatarstan.Material and methods. The study included 101 patients diagnosed with IBD and COVID-19, who were obser

Externí odkaz: https://doaj.org/article/77a701533aa14d3eb87dedbb55071a14

Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial

Autor: Marina G. Avdeeva, Oksana N. Belousova, Ekaterina A. Orlova, Rustem F. Khamitov, Yury G. Shvarts, Irina E. Kravchenko

Publikováno v: Терапевтический архив, Vol 94, Iss 11, Pp 1268-1277 (2022)

Background. A multicenter, double-blind, placebo-controlled, randomized clinical trial (RCT) of the phase III efficacy and safety of Ergoferon for the non-specific prevention of COVID-19 during vaccination against a new coronavirus infection was cond

Externí odkaz: https://doaj.org/article/639462bd110e46d9b97cb429ec4b9b5f